The Economic Ripple of Medicare’s Prostate Cancer Spending: Trends, Challenges, and What Retirees Can Do
Picture this: you’re planning a dream vacation, but every time you check the price tag, it’s higher than you imagined. That’s the reality many retirees face with Medicare’s prostate-cancer drug bill - a bill that jumped from $5.2 billion in 2015 to $8.4 billion